John R. Palumbo - 06 Oct 2025 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Reporting relationship: Director
Issuer ticker: LUCD
Reported as of: 06 Oct 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Oct 2025, 16:46:05 UTC
Prior SEC filing: 07 Oct 2025
Next SEC filing: 24 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael A. Gordon, by power of attorney

Key filing fact

John R. Palumbo filed Form 4 for Lucid Diagnostics Inc. (LUCD) on 07 Oct 2025.

Key facts

This page summarizes John R. Palumbo's Form 4 filing for Lucid Diagnostics Inc. (LUCD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Oct 2025, 16:46.

Change

Previous filing in this sequence was filed on 07 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001251475 Primary reporting owner

PALUMBO JOHN R

Relationship: Director
Address: 360 MADISON AVENUE, 25TH FLOOR, NEW YORK
Signature: /s/ Michael A. Gordon, by power of attorney
Signature date: 07 Oct 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LUCD transaction Derivative

Employee stock option (right to buy)

Award

Transaction value: $0
Shares: +215,000
Change %
Price: $0.000000
Shares after: 215,000
Date: 06 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 215,000
Exercise price: $1.03
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option was granted pursuant to the issuer's Amended and Restated 2018 Long-Term Incentive Equity Plan. One third of the option vests on June 30, 2026 and the balance vests in eight equal quarterly installments, starting September 30, 2026 and ending on June 30, 2028.